IRE1 also activates ERK1/2 (Darling and Cook, 2014), and the inhibition of the MEK/ERK pathway in the breast cancer cell line U0126 renders cancer cells to become more sensitive to ERS-induced apoptosis (Yang et al., 2016). The gene discussed is ERN1; the disease is breast cancer.